Načítá se...
SUN-172 Diabetic Ketoacidosis Precipitated by Treatment with PD-1 Inhibitor: A Rare Immune Related Adverse Event
Introduction: Programmed cell death protein 1 (PD-1) inhibitors stimulate the immune system to produce anti-tumor effects and are among a novel drug class of cancer immunotherapy. PD-1 inhibitors are associated with various immune related adverse events (IRAEs) owing to their indiscriminate activati...
Uloženo v:
| Vydáno v: | J Endocr Soc |
|---|---|
| Hlavní autor: | |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Endocrine Society
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6553092/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/js.2019-SUN-172 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|